Chlamydia&nbsp;
Chlamydial infection, caused by Chlamydia trachomatis, is the most common bacterial sexually transmitted infection (STI). Age is a strong predictor of risk for chlamydial infections, with the highest infection rates in women occurring during ages 15&ndash;24 years. As most individuals with the infection are asymptomatic, it is often left untreated, increasing the risk of transmission and serious health consequences in both sexes.
&nbsp;
Chlamydia Epidemiology Segmentation in the 7MM
The <a href="https://www.delveinsight.com/report-store/chlamydia-infections-epidemiology-forecast">Chlamydia segmentation</a> is as follows:
<ul>
<li class="ql-align-justify">Diagnosed Incident Cases of Chlamydia</li>
<li class="ql-align-justify">Gender-specific Cases of Chlamydia</li>
<li class="ql-align-justify">Symptom-specific Cases of Chlamydia</li>
<li class="ql-align-justify">Age-specific Cases of Chlamydia</li>
</ul>
&nbsp;
Chlamydia Epidemiological Insights Observed in the 7MM (2021)
<ul>
<li class="ql-align-justify">The total diagnosed incident cases of Chlamydia in the 7MM were found to be 3.4 million in the year 2021.</li>
<li class="ql-align-justify">The total diagnosed incident cases of Chlamydia in the US were observed to be 1.9 million in the year 2021.</li>
<li class="ql-align-justify">The total diagnosed incident cases of Chlamydia in Germany were estimated to be 446k.</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/chlamydia-market" target="_blank" rel="noopener noreferrer">Chlamydia Market Insight</a>
The market size of Chlamydia in the 7MM was found to be USD 59.5 million in 2021. &nbsp;
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/chlamydia-pipeline-insight" target="_blank" rel="noopener noreferrer">Chlamydia Emerging Therapies</a>
The emerging drugs in the Chlamydia market are
<ul>
<li class="ql-align-justify">EVO100</li>
<li class="ql-align-justify">Chlamydia infection blockers (CIBs)</li>
<li class="ql-align-justify">VPI-201</li>
<li class="ql-align-justify">Salmonella-Based Vaccine</li>
</ul>
&nbsp;
Chlamydia Key Players&nbsp;
&nbsp;
The key players working in the Chlamydia market are
&nbsp;
<ul>
<li class="ql-align-justify">Evofem Biosciences</li>
<li class="ql-align-justify">QureTechBio</li>
<li class="ql-align-justify">Vault Pharma</li>
<li class="ql-align-justify">Aeterna Zentaris, and several others</li>
</ul>
&nbsp;

Chlamydia Market

Chlamydia Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape